Biopharmaceuticals Dominate Healthcare-Related InvestmentHealthcare received 18% of all venture capital investment during the third quarter of 2012, dropping the industry down to third place. Compared with the same period last year, investment fell 32% to €179 million. So too did deal flow, by 55% to 31 deals completed. Despite attracting an 85% share of all healthcare-related investment for the quarter, the biopharmaceuticals sector still experienced a slight decrease of 4% in investment from the same period a year ago, raising €153 million through 21 deals. Investments in the medical devices and equipment sector slumped to €14 million in seven deals during the third quarter, a drop of 86% in amount invested and 76% in deal flow.
Software Most Popular Sector For European Venture Investment In Third Quarter This Year
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.